BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677
101 results:

  • 1. Quercetin and tanshinone prevent mitochondria from oxidation and autophagy to inhibit KGN cell apoptosis through the SIRT1/SIRT3-foxo3a axis.
    Wan Q; Tang L; Jin K; Chen X; Li Y; Xu X
    Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):257-263. PubMed ID: 38430013
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis.
    Sato S; Ishii M; Tachibana K; Furukawa Y; Toyota T; Kinoshita S; Azusawa Y; Ando J; Ando M
    Exp Hematol; 2024 Feb; 130():104132. PubMed ID: 38029851
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling.
    Xing X; Liu M; Wang X; Guo Q; Wang H; Wang W
    J Cell Mol Med; 2024 Jan; 28(1):e18041. PubMed ID: 37987202
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma.
    Lan J; Wang Y; Yue S; Xu D; Li Y; Peng X; Hu J; Ju E; He S; Li T
    PLoS Pathog; 2023 Aug; 19(8):e1011581. PubMed ID: 37594999
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Multiomics and Multidimensional Testing for Efficacy Monitoring of Patients with lymphoma].
    Wang XH; Yang YX; Wang YJ; Yue BH; Zhang MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):746-752. PubMed ID: 37356935
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Regulation of Baicalin on Growth of Extranodal NK/T Cell lymphoma Cells through foxo3/
    Duan XH; Li H; Lyu Y; Liu J; Wang SX; Wu ZT; Wang BX; Lu M; Wang JH; Liang R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):730-738. PubMed ID: 37356933
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The discrete roles of individual FOXO transcription factor family members in B-cell malignancies.
    Lees J; Hay J; Moles MW; Michie AM
    Front Immunol; 2023; 14():1179101. PubMed ID: 37275916
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction.
    Selli ME; Landmann JH; Terekhova M; Lattin J; Heard A; Hsu YS; Chang TC; Chang J; Warrington J; Ha H; Kingston N; Hogg G; Slade M; Berrien-Elliott MM; Foster M; Kersting-Schadek S; Gruszczynska A; DeNardo D; Fehniger TA; Artyomov M; Singh N
    Blood; 2023 Jun; 141(26):3153-3165. PubMed ID: 37130030
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Ras interacting protein 1 facilitated proliferation and invasion of diffuse large B-cell lymphoma cells.
    Xing X; Wang X; Liu M; Guo Q; Wang H
    Cancer Biol Ther; 2023 Dec; 24(1):2193114. PubMed ID: 36967521
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The CRL4
    Tseng C; Han Y; Lv Z; Song Q; Wang K; Shen H; Chen Z
    J Mol Med (Berl); 2023 Feb; 101(1-2):171-181. PubMed ID: 36688959
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia.
    Sinclair PB; Cranston RE; Raninga P; Cheng J; Hanna R; Hawking Z; Hair S; Ryan SL; Enshaei A; Nakjang S; Rand V; Blair HJ; Moorman AV; Heidenreich O; Harrison CJ
    Leukemia; 2023 Mar; 37(3):636-649. PubMed ID: 36670235
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Noncanonical β-catenin interactions promote leukemia-initiating activity in early T-cell acute lymphoblastic leukemia.
    Panelli P; De Santis E; Colucci M; Tamiro F; Sansico F; Miroballo M; Murgo E; Padovano C; Gusscott S; Ciavarella M; Chavez EA; Bianchi F; Rossi G; Carella AM; Steidl C; Weng AP; Giambra V
    Blood; 2023 Mar; 141(13):1597-1609. PubMed ID: 36315912
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.
    Jang JY; Hwang I; Pan H; Yao J; Alinari L; Imada E; Zanettini C; Kluk MJ; Wang Y; Lee Y; Lin HV; Huang X; Di Liberto M; Chen Z; Ballman KV; Cantley LC; Marchionni L; Inghirami G; Elemento O; Baiocchi RA; Chen-Kiang S; Belvedere S; Zheng H; Paik J
    J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36282572
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic and therapeutic significance of XPO1 in T-cell lymphoma.
    Nie D; Xiao X; Chen J; Xie S; Xiao J; Yang W; Liu H; Wang J; Ma L; Du Y; Huang K; Li Y
    Exp Cell Res; 2022 Jul; 416(2):113180. PubMed ID: 35489384
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Yellow Chaste Weed and Its Components, Apigenin and Galangin, Affect Proliferation and Oxidative Stress in Blue Light-Irradiated HaCaT Cells.
    Park JY; Park SH; Oh SW; Kwon K; Yu E; Choi S; Yang S; Han SB; Jung K; Song M; Cho JY; Lee J
    Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334874
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Interaction of transcription factor foxo3 with histone acetyltransferase complex subunit TRRAP modulates gene expression and apoptosis.
    Fusi L; Paudel R; Meder K; Schlosser A; Schrama D; Goebeler M; Schmidt M
    J Biol Chem; 2022 Mar; 298(3):101714. PubMed ID: 35151693
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association of
    Yu C; Hodge AM; Wong EM; Joo JE; Makalic E; Schmidt D; Buchanan DD; Hopper JL; Giles GG; Southey MC; Dugué PA
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943892
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. B Cell Receptor-Responsive miR-141 Enhances Epstein-Barr Virus Lytic Cycle via foxo3 Inhibition.
    Chen Y; Fachko DN; Ivanov NS; Skalsky RL
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33853871
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Role of Forkhead box O3a transcription factor in autoimmune diseases.
    Xu S; Ma Y; Chen Y; Pan F
    Int Immunopharmacol; 2021 Mar; 92():107338. PubMed ID: 33412391
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia/lymphoma syndrome.
    Liu Y; Cai B; Chong Y; Zhang H; Kemp CA; Lu S; Chang CS; Ren M; Cowell JK; Hu T
    Cell Death Dis; 2020 Oct; 11(10):884. PubMed ID: 33082322
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.